In the News

The authors discuss how the clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials.

Amy Lavelle and Laura Brunner discuss the factors to assess, such as type of work, regulatory considerations and the study’s needs.

Company thought leaders discuss the impact of COVID and regulatory frameworks for clinical trials today.

Brian Ford notes that making an FSP model work takes coordination and accountability, which is where an implementation lead can prove valuable.

Collaboration demonstrates Thermo Fisher’s continuing commitment to advance decentralized trial solutions for customers and patients.

Christopher Gruenloh comments on the state of play for inhaled drugs and how the pharmaceutical laboratory is evolving to accommodate new development.

Innovative decentralized clinical trial solution to help identify, recruit and retain trial participants.

Susan McCune discusses challenges in pediatric development, collaborations between the regulatory agencies and future trends in pediatrics.

Tim Rich explains how decentralized clinical trials can solve numerous pain points for patients in clinical research.